| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +891685.25% |
| VRNA | Verona Pharma Plc | $77.75B | +623824.79% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +523813.33% |
| ARGX | Argen X SE | $54.32B | +435845.31% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +313953.81% |
| ONC | BeiGene Ltd | $34.73B | +278629.59% |
| RVMD | Revolution Medicines Inc | $30.63B | +245685.04% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +189078.34% |
| BNTX | BioNTech SE | $23.52B | +188634.40% |
| INSM | Insmed Inc | $23.04B | +184779.88% |
| ROIV | Roivant Sciences Ltd | $21.31B | +170897.39% |
| INCY | Incyte Corp | $19.46B | +156090.85% |
| MRNA | Moderna Inc | $18.90B | +151582.33% |
| GMAB | Genmab | $17.06B | +136773.06% |
| ASND | Ascendis Pharma A/S | $15.18B | +121715.31% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +117907.68% |
| SMMT | Summit Therapeutics Inc | $13.47B | +108010.41% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +104247.93% |
| EXEL | Exelixis Inc | $12.69B | +101758.90% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +101736.33% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +97472.48% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +96674.74% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +89007.48% |
| ABVX | Abivax | $10.29B | +82448.97% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +81140.71% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +79744.72% |
| CYTK | Cytokinetics Inc | $9.51B | +76222.08% |
| KRYS | Krystal Biotech Inc | $9.03B | +72336.01% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +67692.38% |
| IBRX | ImmunityBio Inc | $8.26B | +66214.95% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +65196.44% |
| TECH | Bio-Techne Corp | $7.53B | +60303.22% |
| MTSR | Metsera Inc | $7.40B | +59322.45% |
| PCVX | Vaxcyte Inc | $7.36B | +58987.85% |
| CORT | Corcept Therapeutics Inc | $6.96B | +55758.92% |
| MRUS | Merus N.V | $6.83B | +54676.28% |
| IMVT | Immunovant Inc | $6.81B | +54579.68% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +53782.24% |
| ACLX | Arcellx Inc | $6.67B | +53394.22% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +52581.45% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +52016.67% |
| CELC | Celcuity Inc | $6.48B | +51878.88% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +50114.57% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +49282.55% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +48302.25% |
| TGTX | TG Therapeutics Inc | $6.00B | +48060.41% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +47629.56% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +47487.94% |
| COGT | Cogent Biosciences Inc | $5.89B | +47194.70% |
| PTCT | PTC Therapeutics Inc | $5.86B | +46898.10% |
| APGE | Apogee Therapeutics Inc | $5.82B | +46622.54% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +45776.48% |
| BLTE | Belite Bio Inc | $5.59B | +44758.40% |
| CGON | Cg Oncology Inc | $5.35B | +42840.87% |
| LEGN | Legend Biotech Corp | $5.26B | +42150.89% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +42020.79% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +41694.64% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +41305.24% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +37863.87% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +37815.35% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +36046.90% |
| TVTX | Travere Therapeutics Inc | $4.41B | +35316.06% |
| AKRO | Akero Therapeutics Inc | $4.38B | +35050.84% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +34786.13% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +34122.06% |
| ERAS | Erasca Inc | $3.88B | +31003.08% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +30992.97% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +30609.51% |
| VKTX | Viking Therapeutics Inc | $3.67B | +29345.43% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +28993.25% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +28829.65% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +26380.15% |
| BEAM | Beam Therapeutics Inc | $3.28B | +26193.49% |
| DNLI | Denali Therapeutics Inc | $3.21B | +25631.79% |
| RCUS | Arcus Biosciences Inc | $3.01B | +24041.16% |
| DYN | Dyne Therapeutics Inc | $3.00B | +23975.52% |
| ORKA | ARCA biopharma Inc | $2.91B | +23246.56% |
| TNGX | Tango Therapeutics Inc | $2.83B | +22633.24% |
| GPCR | Structure Therapeutics Inc | $2.81B | +22450.97% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +21901.24% |
| RLAY | Relay Therapeutics Inc | $2.73B | +21810.66% |
| ALMS | Alumis Inc | $2.67B | +21305.39% |
| IRON | Disc Medicine Inc | $2.66B | +21280.00% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +21123.28% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +20635.54% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +20543.80% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +20134.62% |
| IMNM | Immunome Inc | $2.50B | +19980.37% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +19757.70% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +19557.32% |
| ETNB | 89bio Inc | $2.34B | +18702.17% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +18351.43% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +17693.22% |
| KOD | Kodiak Sciences Inc | $2.18B | +17402.92% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +16807.99% |
| ZLAB | Zai Lab Ltd | $2.08B | +16552.12% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +16208.30% |
| MESO | Mesoblast Ltd | $2.02B | +16095.75% |
| TYRA | Tyra Biosciences Inc | $1.97B | +15730.24% |
| SION | Sionna Therapeutics Inc | $1.96B | +15610.07% |
| STOK | Stoke Therapeutics Inc | $1.96B | +15608.65% |
| NBTX | Nanobiotix | $1.94B | +15442.02% |
| AAPG | Ascentage Pharma Group International | $1.93B | +15409.36% |
| PHVS | Pharvaris NV | $1.92B | +15344.53% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +15264.11% |
| GLPG | Galapagos NV | $1.90B | +15133.64% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +15058.25% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +14901.82% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +14790.75% |
| ADMA | Adma Biologics Inc | $1.84B | +14663.87% |
| NVAX | Novavax Inc | $1.82B | +14533.20% |
| ZYME | Zymeworks BC Inc | $1.81B | +14443.07% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +14396.36% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +14184.55% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +14091.67% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +14031.48% |
| VCEL | Vericel Corp | $1.75B | +13928.65% |
| OCS | Oculis Holding AG | $1.74B | +13897.13% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +13834.21% |
| BHVN | Biohaven Ltd | $1.70B | +13536.27% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +13529.29% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +13398.83% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +13384.84% |
| ANAB | AnaptysBio Inc | $1.67B | +13340.20% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +13254.49% |
| ABCL | AbCellera Biologics Inc | $1.65B | +13169.09% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +13156.07% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +13080.52% |
| INVA | Innoviva Inc | $1.63B | +13007.84% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +12891.03% |
| NKTR | Nektar Therapeutics | $1.62B | +12882.39% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +12872.03% |
| QURE | uniQure N.V. | $1.59B | +12632.08% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +12573.37% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +12454.34% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +12385.60% |
| PGEN | Precigen Inc | $1.55B | +12354.91% |
| IMTX | Immatics N.V | $1.53B | +12207.22% |
| ARDX | Ardelyx Inc | $1.52B | +12128.74% |
| MBX | MBX Biosciences Inc | $1.52B | +12070.32% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +11974.05% |
| VIR | Vir Biotechnology Inc | $1.47B | +11674.55% |
| IMCR | Immunocore Holdings plc | $1.45B | +11534.09% |
| URGN | UroGen Pharma Ltd | $1.43B | +11364.66% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +11251.44% |
| GHRS | GH Research PLC | $1.39B | +11031.36% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +10915.57% |
| SEPN | Septerna Inc | $1.34B | +10638.00% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +10620.82% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +10430.02% |
| MAZE | Maze Therapeutics Inc | $1.30B | +10297.74% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +10088.02% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +9888.24% |
| TRML | Tourmaline Bio Inc | $1.24B | +9816.72% |
| WVE | Wave Life Sciences Ltd | $1.22B | +9685.88% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +8956.36% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +8947.96% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +8713.41% |
| MNKD | Mannkind Corp | $1.10B | +8700.41% |
| DBVT | DBV Technologies | $1.10B | +8690.27% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +8625.52% |
| SVRA | Savara Inc | $1.07B | +8467.87% |
| JBIO | Jade Biosciences Inc | $1.06B | +8414.05% |
| CVAC | CureVac N.V. | $1.05B | +8320.70% |
| ANNX | Annexon Inc | $1.05B | +8300.10% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +7914.73% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +7843.71% |
| CGEM | Cullinan Oncology Inc | $953.73M | +7553.67% |
| PHAR | Pharming Group N.V. | $940.58M | +7448.20% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +7313.41% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +7233.57% |
| KURA | Kura Oncology Inc | $908.93M | +7194.21% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +7167.62% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +7025.53% |
| JANX | Janux Therapeutics Inc | $878.90M | +6953.17% |
| XNCR | Xencor Inc | $868.03M | +6865.96% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +6747.04% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +6673.53% |
| GERN | Geron Corp | $843.41M | +6668.41% |
| EVMN | Evommune Inc | $841.03M | +6649.28% |
| VOR | Vor Biopharma Inc | $840.96M | +6648.73% |
| TBPH | Theravance Biopharma Inc | $837.63M | +6622.03% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +6598.49% |
| SANA | Sana Biotechnology Inc | $825.64M | +6525.78% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +6364.17% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +6297.23% |
| OMER | Omeros Corporation | $797.02M | +6296.14% |
| ABSI | Absci Corp | $789.28M | +6234.02% |
| CMRX | Chimerix Inc | $766.03M | +6047.41% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +6011.08% |
| ANRO | Alto Neuroscience Inc | $714.55M | +5634.28% |
| ATXS | Astria Therapeutics Inc | $709.95M | +5597.37% |
| DSGN | Design Therapeutics Inc | $693.10M | +5462.14% |
| SLDB | Solid Biosciences Inc | $690.73M | +5443.13% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +5382.36% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +5320.18% |
| CRMD | CorMedix Inc | $663.22M | +5222.39% |
| IVA | Inventiva | $655.21M | +5158.11% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +5094.66% |
| CABA | Cabaletta Bio Inc | $640.38M | +5039.10% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +5032.89% |
| PRME | Prime Medicine Inc | $596.03M | +4683.16% |
| CADL | Candel Therapeutics Inc | $589.73M | +4632.56% |
| CBIO | Crescent Biopharma Inc | $573.22M | +4500.11% |
| TECX | AvroBio Inc | $573.01M | +4498.42% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +4484.79% |
| ARVN | Arvinas Inc | $570.83M | +4480.88% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +4320.48% |
| VALN | Valneva SE | $545.52M | +4277.83% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +4255.87% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +4239.26% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +4219.86% |
| MDXG | Mimedx Group Inc | $537.64M | +4214.59% |
| PRTA | Prothena Corporation plc | $532.36M | +4172.24% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +4072.80% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +3927.25% |
| XOMA | XOMA Corp | $497.12M | +3889.38% |
| STRO | Sutro Biopharma Inc | $491.87M | +3847.26% |
| OCGN | Ocugen Inc | $466.88M | +3646.72% |
| SVA | Sinovac Biotech Ltd | $464.94M | +3631.14% |
| IMMX | Immix Biopharma Inc | $462.80M | +3613.95% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +3612.41% |
| STTK | Shattuck Labs Inc | $458.03M | +3575.67% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +3524.12% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +3522.58% |
| UPB | Upstream Bio Inc | $449.51M | +3507.32% |
| AUTL | Autolus Therapeutics plc | $447.12M | +3488.16% |
| ADCT | Adc Therapeutics SA | $438.08M | +3415.63% |
| ASMB | Assembly Biosciences Inc | $435.45M | +3394.50% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +3370.22% |
| AURA | Aura Biosciences Inc | $430.49M | +3354.69% |
| OVID | Ovid Therapeutics Inc | $424.86M | +3309.49% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +3267.27% |
| IPSC | Century Therapeutics Inc | $415.14M | +3231.48% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +3181.72% |
| CMPX | Compass Therapeutics Inc | $408.80M | +3180.63% |
| CYBN | Cybin Inc | $408.43M | +3177.68% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +3140.21% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +3135.81% |
| BNTC | Benitec Biopharma Inc | $398.51M | +3098.05% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +3032.04% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +3031.27% |
| CCCC | C4 Therapeutics Inc | $389.10M | +3022.50% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +3017.50% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +2976.11% |
| RVNC | Revance Therapeutics Inc | $380.38M | +2952.53% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +2950.38% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +2926.25% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +2925.30% |
| OABI | OmniAb Inc | $374.99M | +2909.30% |
| REPL | Replimune Group Inc | $374.27M | +2903.50% |
| ALT | Altimmune Inc | $373.67M | +2898.75% |
| VSTM | Verastem Inc | $373.33M | +2896.00% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +2892.72% |
| PBYI | Puma Biotechnology Inc | $371.93M | +2884.72% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +2834.49% |
| CLLS | Cellectis | $364.91M | +2828.44% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +2822.10% |
| EDIT | Editas Medicine Inc | $349.39M | +2703.82% |
| PALI | Palisade Bio Inc | $346.56M | +2681.18% |
| RGNX | Regenxbio Inc | $345.32M | +2671.18% |
| IMRX | Immuneering Corp Class A | $344.95M | +2668.27% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +2663.61% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +2654.86% |
| FBRX | Forte Biosciences Inc | $340.15M | +2629.73% |
| IMAB | I-Mab | $339.64M | +2625.59% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +2584.87% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +2537.73% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +2520.82% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +2518.40% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +2510.54% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +2496.65% |
| SLN | Silence Therapeutics Plc | $321.20M | +2477.60% |
| RZLT | Rezolute Inc | $319.69M | +2465.52% |
| IVVD | Invivyd Inc | $319.57M | +2464.54% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +2456.46% |
| ANL | Adlai Nortye Ltd | $317.46M | +2447.59% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +2348.11% |
| SCPH | scPharmaceuticals Inc | $304.59M | +2344.35% |
| NAGE | Niagen Bioscience Inc | $304.32M | +2342.18% |
| SRZN | Surrozen Inc | $304.03M | +2339.81% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +2330.47% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +2273.98% |
| IRD | Ocuphire Pharma Inc | $295.61M | +2272.25% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +2221.80% |
| ACIU | AC Immune SA | $289.11M | +2220.14% |
| TENX | Tenax Therapeutics Inc | $288.39M | +2214.36% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +2195.54% |
| YDES | YD Bio Ltd | $278.91M | +2138.26% |
| MGNX | Macrogenics Inc | $278.39M | +2134.11% |
| FATE | Fate Therapeutics Inc | $275.57M | +2111.42% |
| CNTX | Context Therapeutics Inc | $273.80M | +2097.25% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +2088.27% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +2060.61% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +2016.20% |
| TARA | Protara Therapeutics Inc | $262.06M | +2003.07% |
| CGEN | Compugen Ltd | $260.97M | +1994.26% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +1965.49% |
| CHRS | Coherus Biosciences Inc | $256.00M | +1954.42% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +1952.59% |
| HUMA | Humacyte Inc | $255.32M | +1948.96% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +1911.82% |
| ALEC | Alector Inc | $245.37M | +1869.07% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +1845.02% |
| THRD | Third Harmonic Bio Inc | $241.86M | +1840.97% |
| CDXS | Codexis Inc | $239.96M | +1825.69% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +1802.09% |
| ADAG | Adagene Inc | $236.93M | +1801.35% |
| NKTX | Nkarta Inc | $236.88M | +1800.99% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +1769.93% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +1758.53% |
| NERV | Minerva Neurosciences Inc | $230.61M | +1750.64% |
| SLRN | Acelyrin Inc | $228.54M | +1734.07% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +1710.44% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +1701.26% |
| CRBU | Caribou Biosciences Inc | $223.96M | +1697.26% |
| KROS | Keros Therapeutics Inc | $223.18M | +1691.01% |
| RNA | Atrium Therapeutics Inc | $222.37M | +1684.55% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +1654.33% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +1647.21% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +1549.87% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +1524.63% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +1519.50% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +1511.04% |
| KRRO | Korro Bio Inc | $198.45M | +1492.60% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +1487.47% |
| DTIL | Precision Biosciences Inc | $195.87M | +1471.84% |
| IMUX | Immunic Inc | $190.70M | +1430.38% |
| QTTB | Q32 Bio Inc | $187.99M | +1408.61% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +1389.70% |
| MDWD | MediWound Ltd | $184.49M | +1380.50% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +1372.26% |
| THAR | Tharimmune Inc | $183.00M | +1368.58% |
| IFRX | InflaRx N.V. | $182.18M | +1361.98% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +1351.02% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +1331.91% |
| GALT | Galectin Therapeutics Inc | $177.81M | +1326.96% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +1292.69% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +1285.11% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +1285.08% |
| HRTX | Heron Therapeutics Inc | $172.54M | +1284.64% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +1279.38% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +1272.25% |
| SPRO | Spero Therapeutics Inc | $169.62M | +1261.22% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +1258.47% |
| THTX | Theratechnologies Inc | $167.34M | +1242.88% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +1237.08% |
| EQ | Equillium Inc | $166.29M | +1234.45% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +1223.42% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +1219.03% |
| MENS | Jyong Biotech Ltd | $164.22M | +1217.87% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +1207.16% |
| IPHA | Innate Pharma | $159.97M | +1183.77% |
| TTRX | Turn Therapeutics Inc | $157.58M | +1164.57% |
| MOLN | Molecular Partners AG | $154.89M | +1142.96% |
| VXRT | Vaxart Inc | $153.61M | +1132.74% |
| HURA | TuHURA Biosciences Inc | $151.32M | +1114.32% |
| NBP | NovaBridge Biosciences. | $150.91M | +1111.07% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +1107.83% |
| AKTX | Akari Therapeutics Plc | $148.12M | +1088.70% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +1066.49% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +1054.14% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +1049.64% |
| PROK | ProKidney Corp - Class A | $137.85M | +1006.25% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +1004.45% |
| GNLX | Genelux Corp | $137.21M | +1001.13% |
| GUTS | Fractyl Health Inc | $136.31M | +993.90% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +962.25% |
| AGEN | Agenus Inc | $131.36M | +954.16% |
| ACOG | Alpha Cognition Inc | $124.77M | +901.25% |
| CRDF | Cardiff Oncology Inc | $123.75M | +893.09% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +866.85% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +863.24% |
| SEER | Seer Inc - Class A | $115.64M | +828.03% |
| ENGN | enGene Holdings Inc | $115.22M | +824.66% |
| RPTX | Repare Therapeutics Inc | $113.91M | +814.15% |
| COYA | Coya Therapeutics Inc | $111.89M | +797.93% |
| PYXS | Pyxis Oncology Inc | $108.70M | +772.30% |
| VANI | Vivani Medical Inc | $108.35M | +769.51% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +753.31% |
| HLVX | HilleVax Inc | $104.74M | +740.53% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +738.74% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +735.43% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +727.77% |
| PEPG | PepGen Inc | $103.13M | +727.61% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +721.79% |
| BMEA | Biomea Fusion Inc | $98.33M | +689.08% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +684.87% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +684.37% |
| ICCC | Immucell Corp | $96.17M | +671.75% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +653.84% |
| ATHA | Athira Pharma Inc | $92.15M | +639.51% |
| FBIO | Fortress Biotech Inc | $91.60M | +635.05% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +629.10% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +619.98% |
| ANIX | Anixa Biosciences Inc | $88.68M | +611.64% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +606.98% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +599.91% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +598.56% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +598.10% |
| PYPD | Polypid Ltd | $86.83M | +596.84% |
| NRXS | Neuraxis Inc | $85.30M | +584.56% |
| LPTX | Leap Therapeutics Inc | $84.76M | +580.19% |
| CSBR | Champions Oncology Inc | $82.35M | +560.85% |
| ACET | Adicet Bio Inc | $81.58M | +554.68% |
| HYFT | MindWalk Holdings Corp | $79.54M | +538.32% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +537.83% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +525.34% |
| FBIOP | Fortress Biotech Inc | $77.72M | +523.71% |
| RLYB | Rallybio Corp | $76.87M | +516.86% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +516.11% |
| GANX | Gain Therapeutics Inc | $75.20M | +503.52% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +499.34% |
| XBIT | XBiotech Inc | $74.39M | +496.98% |
| OSTX | OS Therapies Inc | $74.24M | +495.74% |
| MCRB | Seres Therapeutics Inc | $73.19M | +487.35% |
| SAVA | Cassava Sciences Inc. | $72.46M | +481.51% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +477.21% |
| EDSA | Edesa Biotech Inc | $70.82M | +468.33% |
| BYSI | BeyondSpring Inc | $70.31M | +464.28% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +451.42% |
| SPRB | Spruce Biosciences Inc | $67.96M | +445.34% |
| CUE | Cue Biopharma Inc | $66.52M | +433.85% |
| IMA | Ikena Oncology Inc | $66.48M | +433.53% |
| MNOV | Medicinova Inc | $65.46M | +425.35% |
| IBIO | iBio Inc | $64.94M | +421.16% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +416.14% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +413.59% |
| IMMP | Immutep Ltd | $63.92M | +412.97% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +410.02% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +407.52% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +407.34% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +397.19% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +391.55% |
| GLTO | Galecto Inc | $60.81M | +388.00% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +375.08% |
| ANVS | Annovis Bio Inc | $57.22M | +359.17% |
| DWTX | Virios Therapeutics Inc | $57.12M | +358.36% |
| ENTX | Entera Bio Ltd | $55.48M | +345.23% |
| TIL | Instil Bio Inc | $55.21M | +343.02% |
| KZR | Kezar Life Sciences Inc | $53.76M | +331.42% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +323.98% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +323.00% |
| NBY | Stablecoin Development Corp | $52.10M | +318.09% |
| RNTX | Rein Therapeutics Inc | $51.79M | +315.65% |
| GOSS | Gossamer Bio Inc | $51.14M | +310.40% |
| MGX | Metagenomi Inc | $50.82M | +307.86% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +301.51% |
| INKT | MiNK Therapeutics Inc | $48.84M | +291.96% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +288.73% |
| XLO | Xilio Therapeutics Inc | $48.23M | +287.02% |
| CING | Cingulate Inc | $47.16M | +278.44% |
| ATYR | Atyr Pharma Inc | $46.89M | +276.28% |
| LVTX | LAVA Therapeutics NV | $45.77M | +267.32% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +266.96% |
| PSTV | Plus Therapeutics Inc | $45.56M | +265.65% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +253.82% |
| KALA | Kala Bio Inc | $43.31M | +247.60% |
| RNXT | RenovoRx Inc | $41.96M | +236.71% |
| NTRB | Nutriband Inc | $41.39M | +232.16% |
| HYPD | Eyenovia Inc | $41.14M | +230.17% |
| FGEN | FibroGen Inc | $39.31M | +215.43% |
| NNVC | NanoViricides Inc | $37.88M | +204.00% |
| VERU | Veru Inc | $37.40M | +200.11% |
| LTRN | Lantern Pharma Inc | $37.25M | +198.96% |
| INMB | INmune Bio Inc | $37.22M | +198.69% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +194.59% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +189.74% |
| GRCE | Acasti Pharma Inc | $36.05M | +189.34% |
| GBIO | Generation Bio Company | $35.97M | +188.65% |
| ABVC | ABVC BioPharma Inc | $35.82M | +187.43% |
| MURA | Mural Oncology plc | $35.34M | +183.62% |
| LITS | Lite Strategy Inc | $35.16M | +182.13% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +178.10% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +175.25% |
| DARE | Dare Bioscience Inc | $33.92M | +172.24% |
| EVAX | Evaxion Biotech A/S | $33.82M | +171.40% |
| BOLD | Boundless Bio Inc | $32.94M | +164.33% |
| SNTI | Senti Biosciences Inc | $31.46M | +152.44% |
| TVRD | Cara Therapeutics Inc | $30.96M | +148.44% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +141.18% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +140.53% |
| APLM | Apollomics Inc - Class A | $29.93M | +140.19% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +133.92% |
| SKYE | Skye Bioscience Inc | $29.10M | +133.55% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +133.03% |
| GRDX | Entero Therapeutics Inc | $28.95M | +132.35% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +129.40% |
| CRVO | CervoMed Inc | $28.15M | +125.88% |
| IGC | IGC Pharma Inc | $28.00M | +124.69% |
| DYAI | Dyadic International Inc DE | $27.40M | +119.87% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +119.62% |
| SER | AgeX Therapeutics Inc | $26.82M | +115.22% |
| PLRZ | Polyrizon Ltd | $26.52M | +112.83% |
| CELU | Celularity Inc - Class A | $26.39M | +111.78% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +111.53% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +111.21% |
| PTN | Palatin Technologies Inc | $26.08M | +109.26% |
| TPST | Tempest Therapeutics Inc | $25.68M | +106.05% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +102.75% |
| PLUR | Pluri Inc | $24.62M | +97.55% |
| MRKR | Marker Therapeutics Inc | $24.21M | +94.33% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +91.10% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +81.98% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +79.09% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +77.58% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +76.20% |
| NXTC | Nextcure Inc | $21.90M | +75.73% |
| OPT | Opthea Ltd | $21.53M | +72.77% |
| CRIS | Curis Inc | $21.11M | +69.40% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +63.52% |
| LGVN | Longeveron Inc - Class A | $19.70M | +58.11% |
| GNTA | Genenta Science SpA | $19.23M | +54.29% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +54.26% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +51.66% |
| XCUR | Exicure Inc | $17.78M | +42.71% |
| INAB | IN8bio Inc | $17.72M | +42.24% |
| PASG | Passage Bio Inc | $17.71M | +42.10% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +38.68% |
| MTVA | MetaVia Inc | $17.25M | +38.42% |
| LPCN | Lipocine Inc | $17.04M | +36.77% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +32.83% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +29.34% |
| HIND | ReShape Lifesciences Inc | $15.72M | +26.17% |
| COCP | Cocrystal Pharma Inc | $15.44M | +23.92% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +23.90% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +22.29% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +20.12% |
| QNCX | Quince Therapeutics Inc | $14.89M | +19.53% |
| APLT | Applied Therapeutics Inc | $14.86M | +19.28% |
| HOOK | Hookipa Pharma Inc | $14.68M | +17.79% |
| BLRX | Bioline Rx Ltd | $14.66M | +17.68% |
| MBRX | Moleculin Biotech Inc | $14.57M | +16.91% |
| IOBT | IO Biotech Inc | $14.50M | +16.35% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +15.06% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +13.53% |
| GTBP | GT Biopharma Inc | $13.91M | +11.61% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +9.66% |
| TOVX | Theriva Biologics Inc | $13.51M | +8.39% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +7.21% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +4.49% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +4.24% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +2.55% |
| CALC | CalciMedica Inc | $11.72M | -5.91% |
| LNAI | Lunai Bioworks Inc | $11.72M | -5.98% |
| TRAW | Traws Pharma Inc | $11.70M | -6.13% |
| INTS | Intensity Therapeutics Inc | $11.33M | -9.07% |
| BIVI | BioVie Inc - Class A | $11.16M | -10.43% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | -10.59% |
| BRTX | BioRestorative Therapies Inc | $11.03M | -11.49% |
| APRE | Aprea Therapeutics Inc | $10.96M | -12.05% |
| KAPA | Kairos Pharma Ltd | $10.68M | -14.26% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -16.33% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | -18.73% |
| MLEC | Moolec Science SA | $10.06M | -19.29% |
| BCDA | BioCardia Inc | $9.85M | -20.96% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | -21.31% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | -21.92% |
| SNGX | Soligenix Inc | $9.11M | -26.93% |
| IMNN | Imunon Inc | $9.02M | -27.60% |
| EPIX | Essa Pharma Inc | $8.93M | -28.33% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -28.44% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | -29.40% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | -30.15% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | -31.47% |
| IMRN | Immuron Ltd | $8.36M | -32.93% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | -34.52% |
| LIMN | Liminatus Pharma Inc | $8.08M | -35.17% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -35.31% |
| NCNA | NuCana plc | $7.95M | -36.21% |
| ADXN | Addex Therapeutics Ltd | $7.90M | -36.61% |
| SYBX | Synlogic Inc | $7.72M | -38.04% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | -38.49% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -41.13% |
| XBIO | Xenetic Biosciences Inc | $7.06M | -43.31% |
| GNPX | Genprex Inc | $7.02M | -43.65% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | -43.97% |
| EVGN | Evogene Ltd | $6.91M | -44.51% |
| SILO | SILO Pharma Inc | $6.78M | -45.56% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | -45.88% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | -46.37% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -48.64% |
| GOVX | Geovax Labs Inc | $6.29M | -49.56% |
| APM | Aptorum Group Ltd - Class A | $6.26M | -49.80% |
| BCAB | BioAtla Inc | $6.19M | -50.32% |
| PPBT | Purple Biotech Ltd | $6.05M | -51.45% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -53.24% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -57.48% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -57.86% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -58.04% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -58.44% |
| HCWB | HCW Biologics Inc | $5.10M | -59.09% |
| PULM | Pulmatrix Inc | $4.97M | -60.14% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -60.60% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -60.64% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | -62.45% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -62.54% |
| ALZN | Alzamend Neuro Inc | $4.38M | -64.89% |
| MBIO | Mustang Bio Inc | $4.29M | -65.57% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -65.77% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -65.78% |
| REVB | Revelation Biosciences Inc | $4.26M | -65.81% |
| FBLG | FibroBiologics Inc | $4.23M | -66.09% |
| ENVB | Enveric Biosciences Inc | $4.15M | -66.68% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -66.79% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -67.25% |
| PHGE | BiomX Inc | $3.91M | -68.65% |
| PBM | Psyence Biomedical Ltd | $3.76M | -69.80% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -70.16% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -71.05% |
| VIVS | VivoSim Labs Inc | $3.36M | -73.00% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -73.18% |
| AZTR | Azitra Inc | $3.32M | -73.35% |
| GRI | GRI Bio Inc | $3.30M | -73.54% |
| SPRC | SciSparc Ltd | $3.05M | -75.56% |
| AFMD | Affimed N.V. | $2.98M | -76.12% |
| CMND | Clearmind Medicine Inc | $2.88M | -76.87% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -76.92% |
| ARTL | Artelo Biosciences Inc | $2.75M | -77.96% |
| OGEN | Oragenics Inc | $2.58M | -79.32% |
| PPCB | Propanc Biopharma Inc | $2.50M | -79.92% |
| NTBL | Notable Labs Inc Ord | $2.39M | -80.78% |
| BBLG | Bone Biologics Corp | $2.23M | -82.14% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -82.78% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -83.24% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -84.00% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -86.00% |
| ONCO | Onconetix Inc | $1.61M | -87.07% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -87.49% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -87.53% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -87.53% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -87.81% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -88.55% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -88.89% |
| JAGX | Jaguar Health Inc | $1.34M | -89.22% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -89.55% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -91.91% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -92.62% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -95.58% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -96.41% |
| ELAB | PMGC Holdings Inc | $221376.00 | -98.22% |
| ADTX | Aditxt Inc | $132564.52 | -98.94% |
| CDT | CDT Equity Inc | $110551.31 | -99.11% |